Document is current
Any future updates will be listed below
-
Authors
Hwang, Sung-Min https://orcid.org/0000-0002-4868-147X
Chang, Shiun
Rodriguez, Paulo C. https://orcid.org/0000-0001-7480-6566
Cubillos-Ruiz, Juan R. https://orcid.org/0000-0002-4267-4893
- License Information
-
More Information
Article History
Accepted: 13 May 2025
First Online: 24 June 2025
Competing interests
: P.C.R. and J.R.C.-R. hold patents on the targeting of ER stress responses for the treatment of disease, as well as on the use of immune modulators for cancer therapy. J.R.C.-R. is a scientific consultant for Autoimmunity Biologic Solutions, Inc., and Emerald Bioventures, LLC, and holds stock options in Vescor Therapeutics.
